These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 30581002

  • 1. Secreted modular calcium-binding protein 2 promotes high fat diet (HFD)-induced hepatic steatosis through enhancing lipid deposition, fibrosis and inflammation via targeting TGF-β1.
    Yuting Y, Lifeng F, Qiwei H.
    Biochem Biophys Res Commun; 2019 Jan 29; 509(1):48-55. PubMed ID: 30581002
    [Abstract] [Full Text] [Related]

  • 2. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y, Sun JP, Wang J, Lu WH, Xie LY, Lv J, Li HX, Yang SF.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):858-865. PubMed ID: 31266632
    [Abstract] [Full Text] [Related]

  • 3. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
    Wu L, Liu Y, Zhao Y, Li M, Guo L.
    Free Radic Biol Med; 2020 Jun 27; 153():140-158. PubMed ID: 32311490
    [Abstract] [Full Text] [Related]

  • 4. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG, An XS.
    Biochem Biophys Res Commun; 2018 Apr 06; 498(3):416-423. PubMed ID: 29454967
    [Abstract] [Full Text] [Related]

  • 5. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L, Wang CC, Song XP, Wang HM, Zhou H, Sun Y, Wang XK, Hou S, Pei FY.
    Biomed Pharmacother; 2018 Sep 06; 105():841-847. PubMed ID: 30021376
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G, Minxuan X, Yuting Q, Tingting G, Jing F, Jinxiao L, Sujun W, Yongjie M, Deshuai L, Qiang L, Linfeng H, Xuyuan N, Mingxing W, Ping H, Jun T.
    Free Radic Biol Med; 2019 Apr 06; 134():23-41. PubMed ID: 30599260
    [Abstract] [Full Text] [Related]

  • 8. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
    Hao YR, Tang FJ, Zhang X, Wang H.
    Biochem Biophys Res Commun; 2018 Sep 05; 503(2):564-571. PubMed ID: 29852170
    [Abstract] [Full Text] [Related]

  • 9. Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.
    Larsen FT, Hansen D, Terkelsen MK, Bendixen SM, Avolio F, Wernberg CW, Lauridsen MM, Grønkjaer LL, Jacobsen BG, Klinggaard EG, Mandrup S, Di Caterino T, Siersbæk MS, Indira Chandran V, Graversen JH, Krag A, Grøntved L, Ravnskjaer K.
    JHEP Rep; 2023 Feb 05; 5(2):100615. PubMed ID: 36687468
    [Abstract] [Full Text] [Related]

  • 10. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
    Bae CR, Hino J, Hosoda H, Miyazato M, Kangawa K.
    Life Sci; 2018 Sep 15; 209():349-356. PubMed ID: 30114411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD, Kong B, Pan Y, Zhan L, Sun R, Aa J, Rizzolo D, Richardson JR, Chen A, Goedken M, Aleksunes LM, Laskin DL, Guo GL.
    Toxicol Appl Pharmacol; 2017 Sep 01; 330():1-8. PubMed ID: 28673684
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation.
    Nagano J, Shimizu M, Hara T, Shirakami Y, Kochi T, Nakamura N, Ohtaki H, Ito H, Tanaka T, Tsurumi H, Saito K, Seishima M, Moriwaki H.
    PLoS One; 2013 Sep 01; 8(9):e73404. PubMed ID: 24039933
    [Abstract] [Full Text] [Related]

  • 15. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2019 Mar 15; 416():1-14. PubMed ID: 30711707
    [Abstract] [Full Text] [Related]

  • 16. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
    Zamani-Garmsiri F, Ghasempour G, Aliabadi M, Hashemnia SMR, Emamgholipour S, Meshkani R.
    IUBMB Life; 2021 Jan 15; 73(1):252-263. PubMed ID: 33326684
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilast.
    Tao X, He H, Peng J, Xu R, Fu J, Hu Y, Li L, Yang X, Feng X, Zhang C, Zhang L, Yu X, Shen A, Huang K, Fu Q.
    Pharmacol Res; 2022 Jan 15; 175():106004. PubMed ID: 34826603
    [Abstract] [Full Text] [Related]

  • 18. Sitagliptin Is More Effective Than Gliclazide in Preventing  Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.
    Ren J, Wang X, Yee C, Gorrell MD, McLennan SV, Twigg SM.
    Molecules; 2022 Jan 22; 27(3):. PubMed ID: 35163991
    [Abstract] [Full Text] [Related]

  • 19. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
    Wu YK, Hu LF, Lou DS, Wang BC, Tan J.
    Biochem Biophys Res Commun; 2020 Mar 26; 524(1):142-149. PubMed ID: 31982140
    [Abstract] [Full Text] [Related]

  • 20. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
    Luo X, Li H, Ma L, Zhou J, Guo X, Woo SL, Pei Y, Knight LR, Deveau M, Chen Y, Qian X, Xiao X, Li Q, Chen X, Huo Y, McDaniel K, Francis H, Glaser S, Meng F, Alpini G, Wu C.
    Gastroenterology; 2018 Dec 26; 155(6):1971-1984.e4. PubMed ID: 30213555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.